Company Filing History:
Years Active: 2006
Title: Inventor Spotlight: Thierry Baltus
Introduction
Thierry Baltus, located in Verlaine, Belgium, is a notable inventor known for his contributions in the field of fluid transfer technology. With one patent to his name, Baltus has made significant strides in enhancing the efficiency and safety of fluid management systems.
Latest Patents
Thierry Baltus holds a patent for a "Method and device for transferring fluid." This innovative device facilitates fluid communication between a sealed container with an access port and at least one fluid passageway. The device is designed with a connector that includes a body defining a fluid passageway between the first and second ends. The first end connects to a fluid source, while the second end attaches to the access port of the container. A locking member secures the position of the body relative to the access port in a locked state, making it ideal for transferring cytotoxic or other drugs. Furthermore, it can remain attached for drug administration using a standard administration set equipped with a male luer connector.
Career Highlights
Throughout his career, Thierry has worked with prominent organizations such as Baxter International Inc. and Baxter Healthcare S.A. His experience in these leading companies has allowed him to enhance his expertise in medical devices and fluid management solutions.
Collaborations
Baltus has collaborated with respected colleagues in the industry, including Ian J. Cuschieri and Jean-Marc Sibenaler. Their combined efforts in research and development have contributed to the innovation of medical technologies, particularly in the area of safe drug transfer systems.
Conclusion
Thierry Baltus is a remarkable inventor whose work continues to influence the medical field positively. His patent for a fluid transfer method and device showcases his commitment to enhancing healthcare technology. As he continues to innovate, the potential for improved safety and efficiency in fluid management remains promising.